140 - CCS/CHFS 2025 GUIDELINE UPDATE FOR PHARMACOLOGIC MANAGEMENT OF HEART FAILURE WITH NON-REDUCED EJECTION FRACTION (LV EJECTION FRACTION > 40%)

Co-Chair(s)

• 

  Sean Virani, MD MSc MPH (he/him/his)

  President
  Canadian Cardiovascular Society
  St. Paul's Hospital | Providence Health Care
• 

  Shelley Zieroth, MD

  Cardiologist
  CHFS
  University of Manitoba

Presenter(s)

• 

  Sean Virani, MD MSc MPH (he/him/his)

  President
  Canadian Cardiovascular Society
  St. Paul's Hospital | Providence Health Care
• 

  Shelley Zieroth, MD

  Cardiologist
  CHFS
  University of Manitoba

Moderator(s)

• CG

  Carolyn Gall Casey, BASc

  Director Guidelines and Knowledge Translation
  Canadian Cardiovascular Society

Planning Committee Member(s)

• 

  Sean Virani, MD MSc MPH (he/him/his)

  President
  Canadian Cardiovascular Society
  St. Paul's Hospital | Providence Health Care
• 

  Shelley Zieroth, MD

  Cardiologist
  CHFS
  University of Manitoba

Workshop Description: This workshop will present the latest Canadian Cardiovascular Society (CCS)/Canadian Heart Failure Society (CHFS) guideline updates on the pharmacologic management of heart failure with non-reduced ejection fraction (LVEF > 40%), encompassing both heart failure with mildly reduced and preserved ejection fraction. The session will highlight evidence-based therapies, and emerging treatments that improve morbidity and quality of life. Clinical cases and interactive discussion will guide participants to implement treatment plans that reflect the evolving understanding for this group of patients.